Listed by the USPTO as GREEN, MALIA NICOLE
Tech Center 1600 • Art Units: 1643
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18477140 | METHODS FOR TREATING INACTIVE THYROID EYE DISEASE | Non-Final OA | Horizon Therapeutics Ireland DAC |
| 18489983 | CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES | Non-Final OA | iBio, Inc. |
| 18484635 | EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III ANTIBODIES | Non-Final OA | iBio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyMalia Nicole Green examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
